FDMT Stock-Based Compensation
4D Molecular Therapeutics Inc · Stock-Based Compensation
FDMT Stock-Based Compensation
Latest reported$20.41Mperiod ending
FDMT TTM Stock-Based Comp ($1.38M → $20.41M)
TTM stock-based compensation
High-resolution chart · PNG
FDMT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 20,409,000 | |
| 19,483,000 | |
| 22,016,000 | |
| 24,041,000 | |
| 26,012,000 | |
| 27,127,000 | |
| 26,115,000 | |
| 24,450,000 | |
| 22,522,000 | |
| 21,418,000 | |
| 19,665,000 | |
| 18,098,000 | |
| 18,056,000 | |
| 17,409,000 | |
| 17,121,000 | |
| 16,506,000 | |
| 15,909,000 | |
| 15,403,000 | |
| 13,799,000 | |
| 11,785,000 | |
| 9,009,000 | |
| 6,230,000 | |
| 4,984,000 | |
| 4,282,000 | |
| 4,189,000 | |
| 3,888,000 | |
| 3,541,000 | |
| 3,013,000 | |
| 2,446,000 | |
| 1,911,500 | |
| 1,377,000 |